Investor Alert

Company Close Updates Archives | Email alerts

Nov. 16, 2020, 5:02 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock falls Monday, underperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 4.69% to $1.22 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.80% to 11,924.13 and the Dow Jones Industrial Average DJIA rising 1.60% to 29,950.44. This was the stock's second consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $8.56 below its 52-week high ($9.78), which the company reached on August 31st.

The stock underperformed when compared to some of its competitors Monday, as Fate Therapeutics Inc. FATE rose 4.53% to $52.80, Vanda Pharmaceuticals Inc. VNDA rose 0.15% to $13.19, and Viking Therapeutics Inc. VKTX rose 2.13% to $6.22. Trading volume (3.0 M) remained 3.4 million below its 50-day average volume of 6.4 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.